Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nafanta Fadiga"'
Autor:
Stéphanie Forté, Gonzalo De Luna, Jameel Abdulrehman, Nafanta Fadiga, Olivia Pestrin, Anne-Laure Pham Hung d’Alexandry d’Orengiani, John Chinawaeze Aneke, Henri Guillet, Dalton Budhram, Anoosha Habibi, Richard Ward, Pablo Bartolucci, Kevin H. M. Kuo
Publikováno v:
Journal of Clinical Medicine. 11:1193
Sickle cell disease (SCD) induces a chronic prothrombotic state. Central venous access devices (CVADs) are commonly used for chronic transfusions and iron chelation in this population. CVADs are an additional venous thromboembolism (VTE) risk factor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32b05f1e5abede1738bb5d234b44e389
https://doi.org/10.3390/jcm11051193
https://doi.org/10.3390/jcm11051193
Autor:
Nafanta Fadiga, Stéphanie Forté, Béland Sébastien, Mathias Castonguay, Melanie Cohn, Denis Soulières, Florence Blais, Kevin H.M. Kuo, Richard Ward
Publikováno v:
Blood. 134:2294-2294
Background: Sickle cell disease (SCD) patients are at significant risk for stroke and silent cerebral infarcts. At least 33% of adults have cognitive dysfunction. However, access to specialized assessments is limited, and there is currently an unmet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bd920c27d4024051834a1907f1dfaf8
https://doi.org/10.1182/blood-2019-129342
https://doi.org/10.1182/blood-2019-129342
Autor:
Nafanta Fadiga, Kevin H.M. Kuo, Stéphanie Forté, Christine Cserti-Gazdewich, Richard Ward, George Tomlinson, Aliraza Rajabali, Jacob Pendergrast, Christopher J. Patriquin, John C Aneke, David Barth
Publikováno v:
Blood. 134:2170-2170
Rate of Sickle Hemoglobin Recovery in Sickle Cell Disease Patients Undergoing Red Blood Cell (RBC) Exchange Transfusion is Associated with Age of Patients and Number of RBC Units Transfused Introduction: Automated and manual red blood cell exchange (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cb179dffec28f8205b0d17361c19fac
https://doi.org/10.1182/blood-2019-122072
https://doi.org/10.1182/blood-2019-122072
Autor:
Shivani Bhat, Nafanta Fadiga, John C Aneke, Kevin H.M. Kuo, Olivia A. Pestrin, Richard Ward, Stéphanie Forté
Publikováno v:
Blood. 132:3518-3518
Introduction: Chronic transfusion is a therapeutic modality in the prevention and treatment of end-organ damage in sickle cell disease (SCD) patients. Central venous access devices (CVAD) are commonly used in many SCD patients due to poor venous acce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed970f967fb87757d2e07e731944c61d
https://doi.org/10.1182/blood-2018-99-119716
https://doi.org/10.1182/blood-2018-99-119716